All In Biotech

Free tool

FAERS Monitor: Levoxyl

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 021301 or its brand name (Levoxyl, Levothyroxine Sodium). Reports on generic versions are filed under their own applications.

Reports

117,966

Serious

78,189

66% of reports

Hospitalization

42,521

Death reported

9,123

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue9,546
  • nausea8,421
  • diarrhoea7,430
  • headache7,381
  • dyspnoea7,101
  • drug ineffective6,732
  • pain6,113
  • dizziness6,004
  • asthenia5,071
  • vomiting5,065
  • malaise4,758
  • fall4,636
  • arthralgia4,591
  • off label use4,474
  • pruritus4,003

Reports by year received

View as table
YearReports
20042,816
20052,856
20062,997
20073,561
20084,841
20094,584
20105,683
20117,244
20128,049
20132,724
20142,580
20153,359
20163,998
20174,313
20184,690
20194,493
20205,872
20216,102
20227,752
20237,252
20247,625
20258,520
20266,054

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 20,936,193 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
fallSignal4,6362.52.44,197
astheniaSignal5,0712.42.44,259
dyspnoeaSignal7,1012.32.25,016
fatigueSignal9,5462.22.26,414
dizzinessSignal6,0042.22.13,785
headacheSignal7,3812.12.14,401
diarrhoeaSignal7,4302.12.04,158
arthralgia4,5912.01.92,244
malaise4,7581.91.92,204
vomiting5,0651.91.92,299
nausea8,4211.91.93,732
pruritus4,0031.91.81,621
pain6,1131.81.72,139
off label use4,4740.90.941
drug ineffective6,7320.90.963

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.